Search

everythinglearnresearchcommunity

for

Search:↓

A genetic marker linked to a type of hair loss was found in most patients studied.

Restoring immune privilege in hair follicles could help treat certain types of hair loss.

Skin bacteria can help wound healing by activating certain immune cells.

Somatostatin may help protect hair follicles from immune attacks.

Some multiple sclerosis treatments may trigger hair loss conditions like alopecia areata.

Transplant success has improved with better immunosuppressive drugs and donor matching.

Two mouse mutations cause similar hair loss despite different skin changes.

Hair loss treatment caused more hair loss in a man.

Half of people with Alopecia Areata may see hair regrowth within a year without treatment, but recovery is unpredictable.

Stress-related substance P may lead to hair loss and negatively affect hair growth.

Despite progress in treatment, the exact cause of Alopecia areata is still unknown.

Certain HLA class II alleles increase or decrease the risk of alopecia areata.

A gene variant increases the risk of a type of hair loss by affecting hair protein production.

MILL molecules are unique immune proteins in mice that don't need TAP to appear on cell surfaces.

A humanized CXCL12 antibody may delay and treat alopecia areata by altering the immune response.

The study found that sweat glands normally suppress immune responses, but this is disrupted in certain skin diseases, possibly contributing to their development.

The document concludes that ongoing research using animal models is crucial for better understanding and treating Alopecia Areata.

Alopecia areata is an autoimmune disease affecting hair follicles and may harm heart health.

Cyclosporine A can reduce inflammation in dogs with sebaceous adenitis, but ongoing treatment is needed.

Ritlecitinib reduces alopecia areata symptoms by blocking JAK3/TEC signaling and T-cell activity.

Farudodstat may effectively treat alopecia areata by protecting hair follicles without harmful effects.

The nail matrix has a reduced immune response, protecting it from autoimmunity.

EGFR deficiency in skin causes hair follicle issues and inflammation.

People with alopecia areata are more likely to have major depression, possibly linked to a specific genetic region.

Ritlecitinib helps reduce inflammation and promote hair regrowth in alopecia areata, especially in patchy-type cases.

Restoring hair follicle immune privilege may help treat alopecia areata.

DM and AA may share a common cause.

Oxidative stress plays a significant role in alopecia areata, and new treatments may include JAK inhibitors and antioxidants.

Blocking certain immune signals can reduce skin damage from radiation therapy.

A new treatment using nanoparticles can effectively prevent and reduce hair loss caused by chemotherapy.